Avila Duby MD is categorized under Rehabilitation Center, Outpatient Treatment in Kissimmee, FL and active since 2002.
Avila Duby MD was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Duby Avila at the company’s single location by writing to 1111 North Central Avenue, Kissimmee, Florida FL 34741 or by phoning (407) 846-6040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Avila Duby MD |
| Contact Person: | Duby Avila |
| Address: | 1111 North Central Avenue, Kissimmee, Florida 34741 |
| Phone Number: | (407) 846-6040 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rehabilitation Center, Outpatient Treatment |
| SIC Code: | 8093 |
| NAICS Code: | 6211110 |
| Share This Business: |
Avila Duby MD was started in 2002 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Duby Avila for inquiries that concern Avila Duby MD by calling the company number (407) 846-6040, as your correspondence is most welcome. Additionally, the physical location of the single location of Avila Duby MD can be found at the coordinates 28.30193,-81.40773 as well as the street address 1111 North Central Avenue in Kissimmee, Florida 34741.
For its online presence, you may visit Avila Duby MD’s website at and engage with its social media outlets through on Twitter and on Facebook.